Pear Therapeutics Inc Class A

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pear Therapeutics Inc. (PEARQ)

12mon ago, source: Nasdaq

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...

Pear Therapeutics, Inc. (PEARQ) stock forecast and price target

8mon ago, source: Yahoo Finance

Find the latest Pear Therapeutics, Inc. PEARQ analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Pear Therapeutics Inc. Warrant (PERWQ)

9mon ago, source: Nasdaq

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...

Is Pear’s demise a sign of things to come for digital therapeutics?

1y ago, source: pharmaphorum

As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker ...

PEAR Therapeutics

6y ago, source: MedCity News

Pear Therapeutics received market authorization from the FDA for its insomnia digital therapeutic, Somryst. It is Pear’s third product to receive FDA clearance, and the first product to be ...

Pear Therapeutics (PEARQ) Earnings Dates & Reports

1mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

FULC Fulcrum Therapeutics, Inc.

15h ago, source: Seeking Alpha

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high ...

ATXS Astria Therapeutics, Inc.

1d ago, source: Seeking Alpha

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Pear Therapeutics, Inc. (PEARQ)

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

PEAR Therapeutics

1y ago, source: pharmaphorum

Digital therapeutics (DTx) company Pear Therapeutics may be heading for a new lease of life, if a plan by former chief executive Corey McCann pays off. Is Pear’s demise a sign of things to come ...